NHGRI logo

The National Human Genome Research Institute supports research and training and career development opportunities in support of its research mission which is to accelerate scientific and medical breakthroughs that improve human health. We do this by driving cutting-edge research, developing new technologies, and studying the impact of genomics on society.

Overview

To apprise the community of research areas that support that mission, NHGRI periodically publishes funding opportunities in the NIH Guide for Grants and Contracts. For your convenience, we have also listed the funding opportunities related to NHGRI on this webpage. NHGRI welcomes innovative investigator-initiated applications and encourages investigators with novel ideas to discuss potential applications with program staff during the concept development stage of the application. If you are considering applying for a Program Announcement with special review (PAR) , a Request for Applications (RFA), or an application that exceeds $500K in direct cost in any one year, we encourage you to review the Guidance to Potential Applicants for NHGRI Support.

For how NHGRI will treat new and non-competing applications, see the FY2021 Funding Policy.

  • Overview

    To apprise the community of research areas that support that mission, NHGRI periodically publishes funding opportunities in the NIH Guide for Grants and Contracts. For your convenience, we have also listed the funding opportunities related to NHGRI on this webpage. NHGRI welcomes innovative investigator-initiated applications and encourages investigators with novel ideas to discuss potential applications with program staff during the concept development stage of the application. If you are considering applying for a Program Announcement with special review (PAR) , a Request for Applications (RFA), or an application that exceeds $500K in direct cost in any one year, we encourage you to review the Guidance to Potential Applicants for NHGRI Support.

    For how NHGRI will treat new and non-competing applications, see the FY2021 Funding Policy.

NHGRI Funding Opportunities

  • Technology Development for Single-Molecule Protein Sequencing (R43/R44 Clinical Trial not allowed)
    PAR-21-247
    Application Due Dates: October 1, 2021; June 15, 2022; June 15, 2023
    Expiration Date: June 16, 2023

  • Technology Development for Single-Molecule Protein Sequencing (R01 Clinical Trial not allowed)
    RFA-HG-21-001
    Application Receipt Date(s): October 1, 2021; June 15, 2022; June 15, 2023 |
    Expiration Date: June 16, 2023
  • Technology Development for Single-Molecule Protein Sequencing (R21 Clinical Trial not allowed)
    RFA-HG-21-002
    Application Receipt Date(s): October 1, 2021; June 15, 2022; June 15, 2023
    Expiration Date: June 16, 2023
  • Notice of Special Interest (NOSI): Advancing Genomic Technology Development for Research and Clinical Application
    NOT-HG-21-018

  • Transformative Nucleic Acid Sequencing Technology Innovation and Early Development (R01 Clinical Trial not Allowed)
    RFA-HG-21-006
    Application Receipt Dates: June 25, 2021; March 1, 2022; February 1, 2023
    Expiration Date: February 2, 2023

  • Transformative Nucleic Acid Sequencing Technology Innovation and Early Development (R21 Clinical Trial not Allowed)
    RFA-HG-21-007
    Application Receipt Dates: June 25, 2021; March 1, 2022; February 1, 2023
    Expiration Date: February 2, 2023

  • Transformative Nucleic Acid Sequencing Technology Innovation and Early Development (R43/R44)
    RFA-HG-21-008
    Application Receipt Dates: June 25, 2021; March 1, 2022; February 1, 2023
    Expiration Date: February 2, 2023

  • Non-Human Primate Developmental Genotype-Tissue Expression (NHP dGTEx) Project (U24 Clinical Trials Not Allowed)
    RFA-HG-21-026
    Application Due Date: August 2, 2021
    Expiration Date: August 3, 2021

  • NIH Directors Early Independence Awards (DP5 Clinical Trial Optional)
    RFA-RF-21-018
    Application Due Date: September 3, 2021
    Expiration Date: September 4, 2021

  • Notice of Intent to Publish a Funding Opportunity Announcement for New Investigators to Promote Workforce Diversity in Genomics and other Health-Related Research (R01 Clinical Trial Optional)
    NOT-HG-21-024

  • Notice of Special Interest (NOSI): High-throughput Molecular and Cellular Phenotyping
    NOT-HG-21-004

  • Center for Inherited Disease Research (CIDR) High Throughput Sequencing and Genotyping Resource Access (X01)
    PAR-20-230
    Application Due Date(s): Applications are accepted by continuous receipt.
    Expiration Date: July 9, 2023
  • Ethical, Legal and Social Implications (ELSI) (Research R01 Clinical Trial Optional)
    PAR-20-254
    Application Due Dates: October 19 2020, February 17 2021, June 17 2021, October 19 2021, February 17 2022, June 17 2022, October 19 2022, February 17 2023, June 19 2023
    Expiration Date: July 20, 2023
     
  • Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21) Clinical Trial Optional)
    PAR-20-255
    Application Due Dates: October 19, 2020, February 17, 2021, June 17, 2021, October 19, 2021, February 17, 2022, June 17, 2022, October 19, 2022, February 17, 2023, June 19, 2023
    Expiration Date: July 20, 2023
     
  • Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03) Clinical Trial Optional)
    PAR-20-257
    Application Due Dates: October 19 2020, February 17 2021, June 17 2021, October 19 2021, February 17 2022, June 17 2022, October 19 2022, February 17 2023, June 19 2023
    Expiration Date: July 20, 2023
     
  • Advancing Genomic Medicine Research (Clinical Trial Optional) (R01)
    RFA-HG-20-036
    Due Dates: August 3, 2020; March 8, 2021; November 2, 2021; August 1, 2022; March 13, 2023
    Expiration Date: March 14, 2023

  • Advancing Genomic Medicine Research (Clinical Trial Optional) (R21)
    RFA-HG-20-037
    Due Dates: August 3, 2020; March 8, 2021; November 2, 2021; August 1, 2022; March 13, 2023
    Expiration Date: March 14, 2023

  • Genomic Community Resources (U24)
    PAR-20-100
    Application Due Date(s): First due date is May 25, 2020; Standard dates apply after that, by 5:00 PM local time of applicant organization.
    Expiration Date: January 26, 2023
     
  • Novel Synthetic Nucleic Acid Technology Development (R01 Clinical Trial not allowed)
    RFA-HG-20-014
    Application Due Date(s): June 24, 2020; February 1, 2021; October 1, 2021; June 24, 2022
    Expiration Date: June 25, 2022

    Notice of Change to Receipt Date for RFA-HG-20-014, RFA-HG-20-015, and RFA-HG-20-016: NHGRI Synthetic Nucleic Acid Technology Development FOAs
    NOT-HG-21-005
     
  • Novel Synthetic Nucleic Acid Technology Development (R21) (Clinical Trial not allowed)
    RFA-HG-20-015
    Application Due Date(s): June 24, 2020; February 1, 2021; October 1, 2021; June 24, 2022
    Expiration Date: June 25, 2022
     
  • Novel Synthetic Nucleic Acid Technology Development (R43/R44) (Clinical Trial Not Allowed)
    RFA-HG-20-016
    Application Due Date(s): June 24, 2020; February 1, 2021; October 1, 2021; June 24, 2022
    Expiration Date: June 25, 2022
     
  • Notice of Special Interest: Genomic Data Repositories (PAR-20-089) and Knowledgebases (PAR-20-097)
    NOT-HG-20-017
     
  • Notice of Special Interest: Development of Statistical, Population Genetics and Computational Methods Related to Polygenic Prediction of Health and Disease in Diverse Populations
    NOT-HG-20-010
     
  • Notice of Change: Emphasizing an Opportunity for New Institutional Applicants in Response to PAR-19-204 Centers of Excellence in Genomic Science (RM1 Clinical Trial Optional)
    NOT-HG-20-013
     
  • NHGRI Implementation of the NIH Genomic Data Sharing Policy
    NOT-HG-20-011
     
  • Notice of New NIH-Designated Data Repository: NHGRI’s Genomic Data Science Analysis, Visualization, and Informatics Lab-space (AnVIL)
    NOT-HG-19-024
     
  • Novel Approaches for Relating Genetic Variation to Function and Disease (R01 Clinical Trial Not Allowed) 
    PAR-18-868
    Application Due Dates: February 5, June 5, October 5
    Expiration Date: July 6, 2021
     
  • Investigator Initiated Research in Computational Genomics and Data Science (R21 Clinical Trial Not Allowed) 
    PAR-18-843 
    Application Due Date(s): November 16, 2018; July 16, 2019; November 16, 2019; July 16, 2020; November 16, 2020; July 16, 2021?
    Expiration Date: September 8, 2021
     
  • Investigator Initiated Research in Computational Genomics and Data Science (R01 Clinical Trial Not Allowed)  
    PAR-18-844
    Application Due Date(s): November 16, 2018; July 16, 2019; November 16, 2019; July 16, 2020; November 16, 2020; July 16, 2021
    Expiration Date: September 8, 2021
  • NHGRI Funding Opportunities
    • Technology Development for Single-Molecule Protein Sequencing (R43/R44 Clinical Trial not allowed)
      PAR-21-247
      Application Due Dates: October 1, 2021; June 15, 2022; June 15, 2023
      Expiration Date: June 16, 2023

    • Technology Development for Single-Molecule Protein Sequencing (R01 Clinical Trial not allowed)
      RFA-HG-21-001
      Application Receipt Date(s): October 1, 2021; June 15, 2022; June 15, 2023 |
      Expiration Date: June 16, 2023
    • Technology Development for Single-Molecule Protein Sequencing (R21 Clinical Trial not allowed)
      RFA-HG-21-002
      Application Receipt Date(s): October 1, 2021; June 15, 2022; June 15, 2023
      Expiration Date: June 16, 2023
    • Notice of Special Interest (NOSI): Advancing Genomic Technology Development for Research and Clinical Application
      NOT-HG-21-018

    • Transformative Nucleic Acid Sequencing Technology Innovation and Early Development (R01 Clinical Trial not Allowed)
      RFA-HG-21-006
      Application Receipt Dates: June 25, 2021; March 1, 2022; February 1, 2023
      Expiration Date: February 2, 2023

    • Transformative Nucleic Acid Sequencing Technology Innovation and Early Development (R21 Clinical Trial not Allowed)
      RFA-HG-21-007
      Application Receipt Dates: June 25, 2021; March 1, 2022; February 1, 2023
      Expiration Date: February 2, 2023

    • Transformative Nucleic Acid Sequencing Technology Innovation and Early Development (R43/R44)
      RFA-HG-21-008
      Application Receipt Dates: June 25, 2021; March 1, 2022; February 1, 2023
      Expiration Date: February 2, 2023

    • Non-Human Primate Developmental Genotype-Tissue Expression (NHP dGTEx) Project (U24 Clinical Trials Not Allowed)
      RFA-HG-21-026
      Application Due Date: August 2, 2021
      Expiration Date: August 3, 2021

    • NIH Directors Early Independence Awards (DP5 Clinical Trial Optional)
      RFA-RF-21-018
      Application Due Date: September 3, 2021
      Expiration Date: September 4, 2021

    • Notice of Intent to Publish a Funding Opportunity Announcement for New Investigators to Promote Workforce Diversity in Genomics and other Health-Related Research (R01 Clinical Trial Optional)
      NOT-HG-21-024

    • Notice of Special Interest (NOSI): High-throughput Molecular and Cellular Phenotyping
      NOT-HG-21-004

    • Center for Inherited Disease Research (CIDR) High Throughput Sequencing and Genotyping Resource Access (X01)
      PAR-20-230
      Application Due Date(s): Applications are accepted by continuous receipt.
      Expiration Date: July 9, 2023
    • Ethical, Legal and Social Implications (ELSI) (Research R01 Clinical Trial Optional)
      PAR-20-254
      Application Due Dates: October 19 2020, February 17 2021, June 17 2021, October 19 2021, February 17 2022, June 17 2022, October 19 2022, February 17 2023, June 19 2023
      Expiration Date: July 20, 2023
       
    • Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21) Clinical Trial Optional)
      PAR-20-255
      Application Due Dates: October 19, 2020, February 17, 2021, June 17, 2021, October 19, 2021, February 17, 2022, June 17, 2022, October 19, 2022, February 17, 2023, June 19, 2023
      Expiration Date: July 20, 2023
       
    • Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03) Clinical Trial Optional)
      PAR-20-257
      Application Due Dates: October 19 2020, February 17 2021, June 17 2021, October 19 2021, February 17 2022, June 17 2022, October 19 2022, February 17 2023, June 19 2023
      Expiration Date: July 20, 2023
       
    • Advancing Genomic Medicine Research (Clinical Trial Optional) (R01)
      RFA-HG-20-036
      Due Dates: August 3, 2020; March 8, 2021; November 2, 2021; August 1, 2022; March 13, 2023
      Expiration Date: March 14, 2023

    • Advancing Genomic Medicine Research (Clinical Trial Optional) (R21)
      RFA-HG-20-037
      Due Dates: August 3, 2020; March 8, 2021; November 2, 2021; August 1, 2022; March 13, 2023
      Expiration Date: March 14, 2023

    • Genomic Community Resources (U24)
      PAR-20-100
      Application Due Date(s): First due date is May 25, 2020; Standard dates apply after that, by 5:00 PM local time of applicant organization.
      Expiration Date: January 26, 2023
       
    • Novel Synthetic Nucleic Acid Technology Development (R01 Clinical Trial not allowed)
      RFA-HG-20-014
      Application Due Date(s): June 24, 2020; February 1, 2021; October 1, 2021; June 24, 2022
      Expiration Date: June 25, 2022

      Notice of Change to Receipt Date for RFA-HG-20-014, RFA-HG-20-015, and RFA-HG-20-016: NHGRI Synthetic Nucleic Acid Technology Development FOAs
      NOT-HG-21-005
       
    • Novel Synthetic Nucleic Acid Technology Development (R21) (Clinical Trial not allowed)
      RFA-HG-20-015
      Application Due Date(s): June 24, 2020; February 1, 2021; October 1, 2021; June 24, 2022
      Expiration Date: June 25, 2022
       
    • Novel Synthetic Nucleic Acid Technology Development (R43/R44) (Clinical Trial Not Allowed)
      RFA-HG-20-016
      Application Due Date(s): June 24, 2020; February 1, 2021; October 1, 2021; June 24, 2022
      Expiration Date: June 25, 2022
       
    • Notice of Special Interest: Genomic Data Repositories (PAR-20-089) and Knowledgebases (PAR-20-097)
      NOT-HG-20-017
       
    • Notice of Special Interest: Development of Statistical, Population Genetics and Computational Methods Related to Polygenic Prediction of Health and Disease in Diverse Populations
      NOT-HG-20-010
       
    • Notice of Change: Emphasizing an Opportunity for New Institutional Applicants in Response to PAR-19-204 Centers of Excellence in Genomic Science (RM1 Clinical Trial Optional)
      NOT-HG-20-013
       
    • NHGRI Implementation of the NIH Genomic Data Sharing Policy
      NOT-HG-20-011
       
    • Notice of New NIH-Designated Data Repository: NHGRI’s Genomic Data Science Analysis, Visualization, and Informatics Lab-space (AnVIL)
      NOT-HG-19-024
       
    • Novel Approaches for Relating Genetic Variation to Function and Disease (R01 Clinical Trial Not Allowed) 
      PAR-18-868
      Application Due Dates: February 5, June 5, October 5
      Expiration Date: July 6, 2021
       
    • Investigator Initiated Research in Computational Genomics and Data Science (R21 Clinical Trial Not Allowed) 
      PAR-18-843 
      Application Due Date(s): November 16, 2018; July 16, 2019; November 16, 2019; July 16, 2020; November 16, 2020; July 16, 2021?
      Expiration Date: September 8, 2021
       
    • Investigator Initiated Research in Computational Genomics and Data Science (R01 Clinical Trial Not Allowed)  
      PAR-18-844
      Application Due Date(s): November 16, 2018; July 16, 2019; November 16, 2019; July 16, 2020; November 16, 2020; July 16, 2021
      Expiration Date: September 8, 2021

NIH-Wide Parent Funding Opportunities

  • PHS 2021-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed)
    PA-21-259
    Expiration Date: April 6, 2022

  • PHS 2021-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required)
    PA-21-260
    Expiration Date: April 6, 2022

    PHS 2021-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required)
    PA-21-261
    Expiration Date: April 6, 2022

    PHS 2021-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed)
    PA-21-262
    Expiration Date: April 2022

  • Change of Recipient Organization (Type 7 Parent Clinical Trial Optional)
    PA-21-268 
    Expiration Date: June 30, 2024
     
  • NIH Director’s Transformative Research Awards (R01 Clinical Trial Optional)
    RFA-RM-21-017
    Application Due Date: September 1, 2021
    Expiration Date: September 2, 2021
     
  • NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)
    PA-21-151
    Application Receipt Date(s): Multiple dates, see announcement.
    Expiration Date: January 8, 2024
     
  • Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Admin Supp)
    PA-20-272 
    Application Receipt Date(s): Multiple dates, see announcement.
    Expiration Date: July 24, 2023

    Guidance for NHGRI Grantees Requesting Administrative Supplements
     
  • Successor-in-Interest (Type 6 Parent Clinical Trial Optional)
    PA-20-275 
    Application Receipt Date(s): A change of grantee organization request must be made before the anticipated start date at the new organization and preferably several months in advance.
    Expiration Date: July 24, 2023
     
  • NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Required)
    PA-20-194
    Application Due Dates: February 16, June 16, October 16
    Expiration Date: May 8, 2023
     
  • NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed)
    PA-20-195
    Application Due Dates: February 16, June 16, October 16
    Expiration Date: May 8, 2023
     
  • NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)
    PA-19-056
    Application Receipt Date(s): February 5, June 5, October 5
    Expiration Date: January 8, 2022
     
  • Research Project Grant (Parent R01 Clinical Trial Required)
    PA-19-055
    Application Receipt Date(s): February 5, June 5, October 5
    Expiration Date: January 8, 2022
     
  • SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance (SB1, R44) Clinical Trial Not Allowed
    PAR-19-334
     
  • Notice of Special Interest: Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Applications Directed at the Adoption of the Fast Healthcare Interoperability Resources (FHIR®) Standard
    NOT-OD-19-127
     
  • Change of Grantee Organization (Type 7 Parent Clinical Trial Optional)
    PA-18-590 
    Application Receipt Date(s): A change of grantee organization request must be made before the anticipated start date at the new organization and preferably several months in advance.
    Expiration Date: January 26, 2021
     
  • NIH Small Research Grant Program (Parent R03 Clinical Trial Not Allowed)
    PA-19-052
  • NIH-Wide Parent Funding Opportunities
    • PHS 2021-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed)
      PA-21-259
      Expiration Date: April 6, 2022

    • PHS 2021-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required)
      PA-21-260
      Expiration Date: April 6, 2022

      PHS 2021-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required)
      PA-21-261
      Expiration Date: April 6, 2022

      PHS 2021-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed)
      PA-21-262
      Expiration Date: April 2022

    • Change of Recipient Organization (Type 7 Parent Clinical Trial Optional)
      PA-21-268 
      Expiration Date: June 30, 2024
       
    • NIH Director’s Transformative Research Awards (R01 Clinical Trial Optional)
      RFA-RM-21-017
      Application Due Date: September 1, 2021
      Expiration Date: September 2, 2021
       
    • NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)
      PA-21-151
      Application Receipt Date(s): Multiple dates, see announcement.
      Expiration Date: January 8, 2024
       
    • Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Admin Supp)
      PA-20-272 
      Application Receipt Date(s): Multiple dates, see announcement.
      Expiration Date: July 24, 2023

      Guidance for NHGRI Grantees Requesting Administrative Supplements
       
    • Successor-in-Interest (Type 6 Parent Clinical Trial Optional)
      PA-20-275 
      Application Receipt Date(s): A change of grantee organization request must be made before the anticipated start date at the new organization and preferably several months in advance.
      Expiration Date: July 24, 2023
       
    • NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Required)
      PA-20-194
      Application Due Dates: February 16, June 16, October 16
      Expiration Date: May 8, 2023
       
    • NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed)
      PA-20-195
      Application Due Dates: February 16, June 16, October 16
      Expiration Date: May 8, 2023
       
    • NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)
      PA-19-056
      Application Receipt Date(s): February 5, June 5, October 5
      Expiration Date: January 8, 2022
       
    • Research Project Grant (Parent R01 Clinical Trial Required)
      PA-19-055
      Application Receipt Date(s): February 5, June 5, October 5
      Expiration Date: January 8, 2022
       
    • SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance (SB1, R44) Clinical Trial Not Allowed
      PAR-19-334
       
    • Notice of Special Interest: Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Applications Directed at the Adoption of the Fast Healthcare Interoperability Resources (FHIR®) Standard
      NOT-OD-19-127
       
    • Change of Grantee Organization (Type 7 Parent Clinical Trial Optional)
      PA-18-590 
      Application Receipt Date(s): A change of grantee organization request must be made before the anticipated start date at the new organization and preferably several months in advance.
      Expiration Date: January 26, 2021
       
    • NIH Small Research Grant Program (Parent R03 Clinical Trial Not Allowed)
      PA-19-052

NIH-Wide Topic Specific Funding Opportunities

  • Notice of Special Interest (NOSI): Synthetic Biology for Biomedical Applications
    NOT-EB-20-017

  • Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed)
    PAR-19-134
    Application Due Dates: Standard Dates
    Expiration Date: January 8, 2022

    NHGRI Notice of Participation in PAR-19-134, "Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed)"
    NOT-HG-21-021

  • Notice of Special Interest (NOSI): Small Business Initiatives for Innovative Diagnostic Technology for Improving Outcomes for Maternal Health
    NOT-EB-21-001
     
  • Understanding and Addressing the Impact of Structural Racism and Discrimination on Minority Health and Health Disparities (R01 Clinical Trial Optional)
    RFA-MD-21-004
    Application Due Date: August 24, 2021
    Expiration Date: August 24, 2021
     
  • Notice of Intent to Publish a Funding Opportunity Announcement for Understanding and Addressing the Impact of Structural Racism and Discrimination on Minority Health and Health Disparities (R01 - Clinical Trial Optional)
    NOT-MD-21-016
  • Notice Announcing the National Human Genome Research Institutes Expectation for Sharing Quality Metadata and Phenotypic Data
    NOT-HG-21-022

  • Notice of NIH Participation in Smart Health and Biomedical Research in the Era of Artificial Intelligence and Advanced Data Science
    NOT-OD-21-011

  •  

  • Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions and Administrative Supplements for Research on Coronavirus Disease 2019 (COVID-19) in Individuals with Down Syndrome for the INCLUDE Project
    NOT-OD-20-129

  • Notice of Common Funds Participation in PA-20-135 "Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional)"
    NOT-RM-20-016

  • Notice of NHGRI’s Participation in PA-18-935 "Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement - Clinical Trial Optional)"
    NOT-HG-20-034

  • Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus
    NOT-HG-20-030

  • Notice of Special Interest (NOSI): Availability of Administrative Supplements to Advance Safe and Effective Therapeutics in Pregnant and Lactating Women and Children
    NOT-HD-20-003

  • Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional)
    PA-20-135
    Application Due Date(s): See the Emergency Notice of Special Interest (NOSI) for any applicable Application Due Dates.
    Expiration Date: March 10, 2023

  • Notice of Special Interest (NOSI): Administrative Supplements to Support Enhancement of Software Tools for Open Science
    NOT-OD-20-073

  • Development of Highly Innovative Tools and Technology for Analysis of Single Cells (STTR) (R41/R42 Clinical Trial Not Allowed)
    PA-20-025
    Application Due Date(s): September 5, January 5, April 5
    Expiration Date: January 6, 2023

  • Development of Highly Innovative Tools and Technology for Analysis of Single Cells (SBIR) (R43/R44 Clinical Trial Not Allowed)
    PA-20-047
    Application Due Date(s): September 5, January 5, April 5
    Expiration Date: January 6, 2023

  • Notice of Special Interest: Administrative Supplements to Promote Research Continuity and Retention of NIH Mentored Career Development (K) Award Recipients and Scholars
    NOT-OD-20-054

  • Notice of Special Interest (NOSI): Ruth L. Kirschstein National Research Service Award (NRSA) Fellowship Awards to Support Training in Research Related to Down Syndrome as Part of the INCLUDE Project
    NOT-OD-20-020

  • Notice of Special Interest (NOSI): Mentored Career Development Awards to Foster the Careers of Investigators Pursuing Research Related to Down syndrome as Part of the INCLUDE Project
    NOT-OD-20-021

  • Notice of Special Interest: Research on the Health of Women of Understudied, Underrepresented and Underreported (U3) Populations (Admin Supp Clinical Trial Optional)
    NOT-OD-20-048

  • Notice of Special Interest: Administrative Supplements for Research on Sex/Gender Influences (Admin Supp Clinical Trial Optional)
    NOT-OD-20-049

  • Notice of NHGRI Participation in PAR-19-372, Social Epigenomics Research Focused on Minority Health and Health Disparities (R01-Clinical Trial Not Allowed)
    NOT-HG-19-026

  • Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)
    PAR-19-274
    Application Receipt/Submission Date(s): February 5, June 5, October 5
    Expiration Date: May 8, 2022

  • Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)
    PAR-19-275
    Application Receipt/Submission Date(s): February 16, June 16, October 16
    Expiration Date: May 8, 2022

  • Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed)
    PAR-19-276
    Application Receipt/Submission Date(s): February 16, June 16, October 16
    Expiration Date: May 8, 2022

  • NIH Highlights Support for Data Science Research through the Academic Research Enhancement Award (AREA) Program
    NOT-GM-19-021 
     
  • Notice of Special Interest in Research on the Health of Sexual and Gender Minority (SGM) Populations
    NOT-MD-19-001 
     
  • National Science Foundation - National Institutes of Health NSF-NIH Interagency Initiative: Smart and Connected Health
    NOT-OD-18-149 
     
  • National Science Foundation - National Institutes of Health NSF-NIH Interagency Initiative: Smart and Connected Health 
    NOT-OD-18-149 
     
  • Announcing the High-Priority, Short-Term Project Award (R56) 
    • Notice of NHGRI's Participation in NOT-OD-04-047 "High Priority, Short-Term Project Award (R56)" 
      NOT-HG-17-004 [grants.nih.gov]
  • NIH-Wide Topic Specific Funding Opportunities
    • Notice of Special Interest (NOSI): Synthetic Biology for Biomedical Applications
      NOT-EB-20-017

    • Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed)
      PAR-19-134
      Application Due Dates: Standard Dates
      Expiration Date: January 8, 2022

      NHGRI Notice of Participation in PAR-19-134, "Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed)"
      NOT-HG-21-021

    • Notice of Special Interest (NOSI): Small Business Initiatives for Innovative Diagnostic Technology for Improving Outcomes for Maternal Health
      NOT-EB-21-001
       
    • Understanding and Addressing the Impact of Structural Racism and Discrimination on Minority Health and Health Disparities (R01 Clinical Trial Optional)
      RFA-MD-21-004
      Application Due Date: August 24, 2021
      Expiration Date: August 24, 2021
       
    • Notice of Intent to Publish a Funding Opportunity Announcement for Understanding and Addressing the Impact of Structural Racism and Discrimination on Minority Health and Health Disparities (R01 - Clinical Trial Optional)
      NOT-MD-21-016
    • Notice Announcing the National Human Genome Research Institutes Expectation for Sharing Quality Metadata and Phenotypic Data
      NOT-HG-21-022

    • Notice of NIH Participation in Smart Health and Biomedical Research in the Era of Artificial Intelligence and Advanced Data Science
      NOT-OD-21-011

    •  

    • Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions and Administrative Supplements for Research on Coronavirus Disease 2019 (COVID-19) in Individuals with Down Syndrome for the INCLUDE Project
      NOT-OD-20-129

    • Notice of Common Funds Participation in PA-20-135 "Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional)"
      NOT-RM-20-016

    • Notice of NHGRI’s Participation in PA-18-935 "Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement - Clinical Trial Optional)"
      NOT-HG-20-034

    • Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus
      NOT-HG-20-030

    • Notice of Special Interest (NOSI): Availability of Administrative Supplements to Advance Safe and Effective Therapeutics in Pregnant and Lactating Women and Children
      NOT-HD-20-003

    • Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional)
      PA-20-135
      Application Due Date(s): See the Emergency Notice of Special Interest (NOSI) for any applicable Application Due Dates.
      Expiration Date: March 10, 2023

    • Notice of Special Interest (NOSI): Administrative Supplements to Support Enhancement of Software Tools for Open Science
      NOT-OD-20-073

    • Development of Highly Innovative Tools and Technology for Analysis of Single Cells (STTR) (R41/R42 Clinical Trial Not Allowed)
      PA-20-025
      Application Due Date(s): September 5, January 5, April 5
      Expiration Date: January 6, 2023

    • Development of Highly Innovative Tools and Technology for Analysis of Single Cells (SBIR) (R43/R44 Clinical Trial Not Allowed)
      PA-20-047
      Application Due Date(s): September 5, January 5, April 5
      Expiration Date: January 6, 2023

    • Notice of Special Interest: Administrative Supplements to Promote Research Continuity and Retention of NIH Mentored Career Development (K) Award Recipients and Scholars
      NOT-OD-20-054

    • Notice of Special Interest (NOSI): Ruth L. Kirschstein National Research Service Award (NRSA) Fellowship Awards to Support Training in Research Related to Down Syndrome as Part of the INCLUDE Project
      NOT-OD-20-020

    • Notice of Special Interest (NOSI): Mentored Career Development Awards to Foster the Careers of Investigators Pursuing Research Related to Down syndrome as Part of the INCLUDE Project
      NOT-OD-20-021

    • Notice of Special Interest: Research on the Health of Women of Understudied, Underrepresented and Underreported (U3) Populations (Admin Supp Clinical Trial Optional)
      NOT-OD-20-048

    • Notice of Special Interest: Administrative Supplements for Research on Sex/Gender Influences (Admin Supp Clinical Trial Optional)
      NOT-OD-20-049

    • Notice of NHGRI Participation in PAR-19-372, Social Epigenomics Research Focused on Minority Health and Health Disparities (R01-Clinical Trial Not Allowed)
      NOT-HG-19-026

    • Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)
      PAR-19-274
      Application Receipt/Submission Date(s): February 5, June 5, October 5
      Expiration Date: May 8, 2022

    • Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)
      PAR-19-275
      Application Receipt/Submission Date(s): February 16, June 16, October 16
      Expiration Date: May 8, 2022

    • Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed)
      PAR-19-276
      Application Receipt/Submission Date(s): February 16, June 16, October 16
      Expiration Date: May 8, 2022

    • NIH Highlights Support for Data Science Research through the Academic Research Enhancement Award (AREA) Program
      NOT-GM-19-021 
       
    • Notice of Special Interest in Research on the Health of Sexual and Gender Minority (SGM) Populations
      NOT-MD-19-001 
       
    • National Science Foundation - National Institutes of Health NSF-NIH Interagency Initiative: Smart and Connected Health
      NOT-OD-18-149 
       
    • National Science Foundation - National Institutes of Health NSF-NIH Interagency Initiative: Smart and Connected Health 
      NOT-OD-18-149 
       
    • Announcing the High-Priority, Short-Term Project Award (R56) 
      • Notice of NHGRI's Participation in NOT-OD-04-047 "High Priority, Short-Term Project Award (R56)" 
        NOT-HG-17-004 [grants.nih.gov]

Last updated: July 23, 2021